BlueCrest Capital Management’s Moderna MRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$517K	–	204
2022 Q1	$517K	Buy	+3,000	New	+$517K	0.02%	172
2020 Q3	–	Sell	-10,206	Closed	-$655K	–	298
2020 Q2	$655K	Buy	+10,206	New	+$655K	0.03%	154